Transference of CALIPER total alkaline phosphatase reference interval to a Brazilian pediatric population Natasha Slhessarenko 1, 2 ; Adagmar Andriolo The reference intervals (RI) represent a set of values used to interpret the results of quantitative laboratory tests and are powerful tools that assist health professionals in making decisions during patient care (1) . The determination of their own RI gives diagnostic power, but it is one of the most arduous and costly tasks in the Clinical Pathology (2, 3) . When it comes to defining RI in the pediatric population, the situation is further complicated, since defining a healthy pediatric population involves, among other procedures, obtaining the anthropometric measurements and collecting blood samples. The concern about not plundering the child and the emotional pressure involved in collecting samples in pediatric patients are care for which we must be aware.
For this reason, the Clinical and Laboratory Standard Institute (CLSI) (4) defined that one of the simplest and least expensive ways to determine RI could be the transference, which is the way by which a previously defined RI is adapted to a new analytical method or to another laboratory. This technique was proposed by the Nordic Reference Interval Children Project (NORICHILD), and later used by the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER). The latter is a Canadian project, multicenter, aimed at developing a comprehensive database of reference values in the healthy children population.
Considering the transference, a successful validation occurs when a number greater than or equal to 90% of the sample values are within the RI that serve as a comparison and this method must be performed in at least 20 samples.
Alkaline phosphatase (ALP) is a group of enzymes found in several tissues, with emphasis on the liver, epithelium of the bile ducts, bone, placenta and intestinal mucosa. The study of ALP isoenzymes allows us to identify the fraction involved in eventual elevation of total ALP. In physiological conditions, the hepatic fraction contributes with 50% of the total serum level of ALP, the bone fraction with 40%, and the intestinal fraction with 10%. Pregnant women produce the placental isoenzyme.
For many decades, medical concern has always been centered on the elevated levels of this enzyme, which, classically, is a marker of osteoblast activity and hepatic injury, particularly in cholestatic conditions.
In the recent years, however, with the description of hypophosphatasia, attention has been focused on the low activity of this enzyme, characterized by decreased serum levels. Hypophosphatasia is a rare, potentially fatal inherited metabolic disease caused by a mutation in the gene that encodes the tissuenonspecific alkaline phosphatase (TNSALP), causing the accumulation of various substances [inorganic pyrophosphate (PPi) in urine, pyridoxal 5'-phosphate (PLP), phosphoethanolamine (PEA)]
